Table 2 Demographic and clinical characteristics of the 125 patients included in the study

Mean age ± SD (years)

59.5 +/- 14

62.7 +/- 12.8

0.19^*

Male sex, n (%)

50 (64.9)

31 (64.6)

0.96^**

Underlying disease, n (%)

Hematological malignancy

37 (48)

19 (39.6)

0.35^**

Solid organ or hematopoietic stem cell transplant

26 (33.7)

13 (27.1)

0.43^**

Solid tumor

14 (18.2)

7 (14.6)

0.60^**

Autoimmune disease

9 (11.7)

5 (10.4)

0.83^**

Lung disease

7 (9.1)

18 (37.5)

< 0.01^**

HIV infection

5 (6.5)

0 (0)

0.07^**

Comorbidity, n (%)

Cardiovascular disease

32 (41.5)

28 (58.3)

0.07^**

Diabetes

13 (16.8)

6 (12.5)

0.50^**

Renal failure

9 (11.7)

2 (4.2)

0.14^**

Immunosuppressive treatment, n (%)

Corticosteroids

22 (28.6)

17 (35.4)

0.44^**

Cytotoxic chemotherapy

23 (29.9)

12 (25)

0.52^**

Anti-Pneumocystis treatment, n (%)

77 (100)

0 (0)

< 0.01^**

Antiviral treatment, n (%)

24 (31.2)

6 (12.5)

0.017^**